Gene G. Kinney | executive |
Tran Nguyen | executive |
Charles Duncan | analyst |
Hideki Garren | executive |
Jay Olson | analyst |
Neena Bitritto-Garg | analyst |
Guofang Li | analyst |
Michael Yee | analyst |
Jason Butler | analyst |
Good day, ladies and gentlemen, and welcome to the Prothena Biosciences Fourth Quarter and Full Year 2023 Financial Results Conference Call. My name is Krista, and I will be your coordinator for today. [Operator Instructions] I would now like to turn the presentation over to Mark Johnson, Vice President of Investor Relations at Prothena. Please proceed.
Thank you, operator.